What human trials say about psyllium and weight Human clinical trials and systematic reviews of psyllium show consistent metabolic signals: reduced post-prandial glucose, improvements in fasting glycemia for people with diabetes, and increased satiety in many short-term studies
Managing obesity doesnt have to be overwhelming
21,23 Managing other preexisting GI conditions, such as gastroesophageal reflux disease or constipation, before initiating GLP-1 RAs can reduce the likelihood of severe GI AEs and improve overall tolerability
Initially developed as a treatment for diabetes, the drug acts to stimulate the secretion of insulin, as well as suppress appetite by delaying gastric emptying and promoting satiety
After four weeks, the dose can rise by 2.5 mg at a time, up to a usual maintenance dose between 5 mg and 15 mg weekly, depending on individual needs